03:07 AM EST, 01/30/2025 (MT Newswires) -- Andrew Cheng, Director, President and Chief Executive Officer, on January 27, 2025, sold 30,000 shares in Akero Therapeutics ( AKRO ) for $1,646,978. Following the Form 4 filing with the SEC, Cheng has control over a total of 716,062 shares of the company, with 716,062 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025010705/xslF345X05/ownership.xml